Annual report pursuant to Section 13 and 15(d)

Convertible Debt - Related Party (Detail Textuals 1)

v3.20.1
Convertible Debt - Related Party (Detail Textuals 1) - USD ($)
1 Months Ended 12 Months Ended
Jan. 19, 2018
Dec. 28, 2017
Dec. 31, 2019
Dec. 31, 2018
Short-term Debt [Line Items]        
Proceeds from convertible debt issuance       $ 400,000
Loss on extinguishment of debt     $ (725,425) $ (590,392)
Emerald Health Sciences Inc        
Short-term Debt [Line Items]        
Initial conversion price $ 0.10      
Number of notes converted into common stock 9,000,000      
Effective interest rate       13.94%
Bridge Loan | Secured Promissory Note and Security Agreement | Emerald Health Sciences Inc        
Short-term Debt [Line Items]        
Aggregate gross proceeds   $ 900,000    
Bridge loan interest rate   12.00%    
Initial conversion price   $ 0.10    
Proceeds from convertible debt issuance   $ 500,000    
Funding of remaining bridge loan $ 400,000      
Convertible debt   265,000    
Additional conversion liability   $ 360,000